Form 4: Aspira Women's Health Director Winfred Parnell Reports Stock Transactions

Director Winfred Parnell reports the vesting and conversion of restricted stock units into common stock of Aspira Women's Health Inc.

Summary

• On September 30, 2024, Winfred Parnell, a director of Aspira Women's Health Inc., reported the vesting of 5,156 restricted stock units (RSUs) which converted into common stock.
• These RSUs were part of a grant of 20,625 RSUs awarded on August 22, 2024, as previously reported on August 26, 2024.
• Following the transaction, Parnell directly owns 55,740 shares of Aspira Women's Health Inc. common stock and 15,469 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine vesting of previously granted equity.

Key Dates

Keywords

Aspira Women's Health Inc., Winfred Parnell, Director, Form 4, Restricted Stock Units, RSUs, Common Stock, Vesting, Conversion, Beneficial Ownership